Low serum T and high-risk prostate cancer in Korean men

A group of Korean researchers have poublished data suggesting that — at least in Korean patients — there may be an association between having a low serum testosterone (serum T) level and diagnosis with high-grade prostate cancer. … READ MORE …

The biology and pathology of “young age” prostate cancer

A recent article in the Journal of Clinical Pathology reviews available data about the epidemiology, biology, and clinical pathology of “young age” prostate cancer, which the authors define as clinically significant cancer in men under 55 years of age. … READ MORE …

Prostate biopsies and effects on erectile function post-biopsy

There have long been suggestions that having a prostate biopsy could be associated with at least a temporary decline in erectile function. A new study in BJU International has now shed more light on this matter. … READ MORE …

Risk for prostate cancer among black males in England

A newly published article in the British Medical Journal has shown that black males in England are twice as likely to be diagnosed with prostate cancer as white males, and are twice as likely to die of prostate cancer too. … READ MORE …

How many “different” types of prostate cancer are there?

This, of course, is a rhetorical question. We really have no good idea how many “different” types of prostate cancer there are. And so what we are really dealing with here is how we are going to sub-classify prostate cancers in the future in order to treat them most appropriately at the earliest relevant stage of development. … READ MORE …

Management of incident prostate cancer on active surveillance

Back in the dim and distant past (i.e., the 1980s and the very early 1990s, before PSA testing was widespread) one of the most common ways to find early stage prostate cancer was as an incidental consequence of the conduct of a transurethral resection of the prostate (a “TURP”) to treat symptoms of urinary tract obstruction. … READ MORE …

Chemo + ADT + RT: no benefit after 10 years

Earlier this month, we looked at the evidence of benefit for adding chemotherapy to androgen deprivation therapy (ADT) + radiation therapy (RT) for high-risk prostate cancer (see “Docetaxel with radiation in prostate cancer treatment”). … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,342 other followers